PM
INSP icon

Prosight Management’s Inspire Medical Systems INSP Stock Holding History

Prosight Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,000
Closed -$1.87M – 51
2024
Q2 		$1.87M Buy
+14,000
New +$2.65M 0.56% 32
2023
Q4 		– Sell
-40,000
Closed -$7.94M – 42
2023
Q3 		$7.94M Buy
+40,000
New +$10.1M 2.52% 13

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prosight Management's INSP Position: Q3 2024 in Review

Prosight Management sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 14,000 shares — an estimated $1.87M sold.

Prosight Management first reported a position in INSP in Q3 2023 and held it in 2 quarters. The position peaked at $7.94M in Q3 2023. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

  • Prosight Management reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
  • Prosight Management sold 14,000 Inspire Medical Systems shares in Q3 2024, an estimated $1.87M.
  • Prosight Management first reported a position in Inspire Medical Systems in Q3 2023 and held it in 2 quarters.
  • Prosight Management's Inspire Medical Systems position peaked at $7.94M in Q3 2023.
  • 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Prosight Management's 13F filing for Q3 2024, filed 14 Nov 2024.